NCT06326996View on ClinicalTrials.gov

Thiamine Intervention and Coronary Artery Bypass Grafting

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Coronary Heart DiseaseCoronary Artery Bypass Grafting
Interventions
DRUG

Thiamine

Participants will be given an infusion of thiamine.

DRUG

Placebo

Participants will be given an infusion of the placebo treatment.

Trial Locations (1)

90095

RECRUITING

UCLA, Los Angeles

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of California, Los Angeles

OTHER